Coherus Oncology Inc. (CHRS)

CHRS trades at $1.5, pinned near the near-term max pain of $1.5 expiring Oct 17, 2025 (19 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($0.5-$1.5), reflecting growing call interest at higher strikes. Key magnetic zone at 1 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for CHRS shows an upward trend from 0.5 to 1.5, suggesting bullish positioning in longer-dated options. The 143% spread signals divergent expectations across timeframes. Most levels below 1.5 may cap rallies. Strong magnetic level at 1 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.